Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04741477 · ClinicalTrials.gov registry record · Phase 1
The Pharmacokinetics and Pharmacodynamics of Hemp-based Topical Cannabinoid Products
A Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 1
- Development phase
- 47
- Enrollment target
NCT04741477: Completed Phase 1 study, sponsored by Johns Hopkins University.
NCT04741477 is a Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04741477, a Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 47 participants
- Enrollment target
Study Summary
This study will evaluate the pharmacokinetic and pharmacodynamic effects of hemp-based Cannabidiol (CBD) topical products (e.g., lotions, creams, patches) that contain low levels of delta-9-tetrahydrocannabinol (THC).
Interventions
- DRUG Placebo
- DRUG THC
- DRUG CBD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2021-07-14 |
| Est. Completion | 2022-09-16 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04741477
The ClinicalTrials.gov registry entry for NCT04741477 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT04741477 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04741477 about?
NCT04741477 is a clinical study titled "The Pharmacokinetics and Pharmacodynamics of Hemp-based Topical Cannabinoid Products". This study will evaluate the pharmacokinetic and pharmacodynamic effects of hemp-based Cannabidiol (CBD) topical products (e.g., lotions, creams, patches) that contain low levels of delta-9-tetrahydrocannabinol (THC).
What is the current status of trial NCT04741477?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 47 participants. The study started on 2021-07-14. Estimated completion is 2022-09-16.
What interventions are being tested in trial NCT04741477?
The interventions under investigation include: Placebo (DRUG), THC (DRUG), CBD (DRUG).
Who is sponsoring clinical trial NCT04741477?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.